Evaluation of the sensitivity and specificity of basal plasma adrenocorticotrophic hormone concentration for diagnosing pituitary pars intermedia dysfunction in horses: A systematic review. (September 2021)

• Record Type: Journal Article
• Authors: Tatum, R.C.; McGowan, C.M.; Ireland, J.L.
• Is Part Of: Veterinary journal. Volume 275(2021)
• Publication Date: 2021-09
• Subjects: ACTH -- Cushing's disease -- Diagnostic accuracy -- Equine -- PPID; Veterinary medicine -- Periodicals; 636
• DOI: 10.1016/j.tvjl.2021.105695
• Languages: English
• ISSNs: 1090-0233

Abstract

Highlights: Robust pituitary pars intermedia dysfunction (PPID) diagnostic accuracy studies are lacking. Adrenocorticotrophic hormone (ACTH) has excellent specificity for PPID diagnosis. ACTH has good sensitivity for PPID diagnosis in animals exhibiting clinical signs. Abstract: Measurement of basal adrenocorticotrophic hormone (ACTH) is currently used to diagnose pituitary pars intermedia dysfunction (PPID) in horses, yet a systematic review of the evidence for its use has not been undertaken. This study aimed to systematically review evidence regarding the sensitivity and specificity of the basal ACTH diagnostic test. Electronic databases were systematically searched in January 2019, September 2020 and January 2021, for English language publications published prior to these dates. Screening, data extraction and quality assessment of publications was undertaken by the authors using predefined criteria. Study design, methodology and information reported in included studies were assessed using Standards for Reporting of Diagnostic Accuracy (STARD) checklists. Risk of bias and applicability were appraised using the Quality Assessment tool for Diagnostic Accuracy Studies (QUADAS-2) quality assessment tool. Due to identified biases and marked between-study variations, meta-analysis was not undertaken. After removal of duplicates, 415 publications were identified, of which 25 were evaluated in full, with 11 of these meeting inclusion criteria. In most studies, basal ACTH was reported to have good sensitivity (overall median 75.5%; interquartile range [IQR], 64.0−86.5%; range, 36.0−100%) and excellent specificity (overall median, 95.2%; IQR, 84.2−98.9%; range, 63.3−100%). However, QUADAS-2 and STARD assessment highlighted that studies did not utilise optimal study design and/or study populations for the evaluation of a diagnostic test and the majority were subject to bias, or provided insufficient information to fully assess possible biases. Based on this review, basal ACTH performed better at ruling out PPID than detecting it.